A survey of frameworks for best practices in weight-of-evidence analyses

Abstract The National Academy of Sciences (NAS) Review of the Environmental Protection Agency’s Draft IRIS Assessment of Formaldehyde proposed a “roadmap” for reform and improvement of the Agency’s risk assessment process. Specifically, it called for development of a transparent and defensible methodology for weight-of-evidence (WoE) assessments. To facilitate development of an improved process, we developed a white paper that reviewed approximately 50 existing WoE frameworks, seeking insights from their variations and nominating best practices for WoE analyses of causation of chemical risks. Four phases of WoE analysis were identified and evaluated in each framework: (1) defining the causal question and developing criteria for study selection, (2) developing and applying criteria for review of individual studies, (3) evaluating and integrating evidence and (4) drawing conclusions based on inferences. We circulated the draft white paper to stakeholders and then held a facilitated, multi-disciplinary invited stakeholder workshop to broaden and deepen the discussion on methods, rationales, utility and limitations among the surveyed WoE frameworks. The workshop developed recommendations for improving the conduct of WoE evaluations. Based on the analysis of the 50 frameworks and discussions at the workshop, best practices in conducting WoE analyses were identified for each of the four phases. Many of these best practices noted from the analysis and workshop could be implemented immediately, while others may require additional refinement as part of the ongoing discussions for improving the scientific basis of chemical risk assessments.

[1]  Ord,et al.  Guidelines for Neurotoxicity Risk Assessment , 2014 .

[2]  U. Epa Guidelines for carcinogen risk assessment , 1986 .

[3]  David Moher,et al.  Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews , 2007, BMC medical research methodology.

[4]  L. V. van Amelsvoort,et al.  A weight of evidence approach to causal inference. , 2009, Journal of clinical epidemiology.

[5]  Jennifer Seed,et al.  A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action , 2003, Critical reviews in toxicology.

[6]  Gábor L. Lövei,et al.  Application of Systematic Review Methodology to Food and Feed Safety Assessments to Support Decision Making , 2010 .

[7]  Abby A. Li,et al.  Integration of epidemiology and animal neurotoxicity data for risk assessment. , 2012, Neurotoxicology.

[8]  Julie E Goodman,et al.  Hypothesis-based weight of evidence: A tool for evaluating and communicating uncertainties and inconsistencies in the large body of evidence in proposing a carcinogenic mode of action—naphthalene as an example , 2010, Critical reviews in toxicology.

[9]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[10]  H. Tilson Guidelines for Neurotoxicity Risk Assessment , 1998 .

[11]  U. Tillmann,et al.  A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. , 1997, Regulatory toxicology and pharmacology : RTP.

[12]  Richard A Becker,et al.  Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's Endocrine Disruptor Screening Program. , 2011, Regulatory toxicology and pharmacology : RTP.

[13]  Pierre R. Bushel,et al.  CEBS—Chemical Effects in Biological Systems: a public data repository integrating study design and toxicity data with microarray and proteomics data , 2007, Nucleic Acids Res..

[14]  Ord,et al.  Framework for Human Health Risk Assessment to Inform Decision Making , 2013 .

[15]  Richard W. Lewis,et al.  Recognition of Adverse and Nonadverse Effects in Toxicity Studies , 2002, Toxicologic pathology.

[16]  R. Tyl Basic Exploratory Research versus Guideline-Compliant Studies Used for Hazard Evaluation and Risk Assessment: Bisphenol A as a Case Study , 2009, Environmental health perspectives.

[17]  Paolo Vineis,et al.  Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans. , 2012, International journal of epidemiology.

[18]  Kim Boekelheide,et al.  Toxicity testing in the 21st century: using the new toxicity testing paradigm to create a taxonomy of adverse effects. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  Sheldon Krimsky,et al.  The weight of scientific evidence in policy and law. , 2005, American journal of public health.

[20]  Michael S Victoroff,et al.  Evidence-based toxicology: a comprehensive framework for causation , 2005, Human & experimental toxicology.

[21]  Alan R. Boobis,et al.  IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for Humans , 2008, Critical reviews in toxicology.

[22]  G. Guyatt,et al.  The GRADE approach and Bradford Hill's criteria for causation , 2010, Journal of Epidemiology & Community Health.

[23]  Patrice Sutton,et al.  An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. , 2011, Health affairs.

[24]  A. B. Hill The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[25]  Causality and the interpretation of epidemiologic evidence. , 2007, Environmental health perspectives.

[26]  E. Youngstrom,et al.  A proposal to facilitate weight-of-evidence assessments: Harmonization of Neurodevelopmental Environmental Epidemiology Studies (HONEES). , 2011, Neurotoxicology and teratology.

[27]  J. Vlaanderen,et al.  Guidelines to Evaluate Human Observational Studies for Quantitative Risk Assessment , 2008, Environmental health perspectives.

[28]  A. B. Hill,et al.  "The Environment and Disease: Association or Causation?" (1965), by Austin Bradford Hill , 2017 .

[29]  J. Goodman,et al.  A framework for assessing causality and adverse effects in humans with a case study of sulfur dioxide. , 2010, Regulatory toxicology and pharmacology : RTP.

[30]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[31]  Igor Linkov,et al.  Weight-of-evidence evaluation in environmental assessment: review of qualitative and quantitative approaches. , 2009, The Science of the total environment.

[32]  Carolyn Vickers,et al.  IPCS framework for analysing the relevance of a cancer mode of action for humans , 2006 .

[33]  Glenn W Suter,et al.  Why and how to combine evidence in environmental assessments: weighing evidence and building cases. , 2011, The Science of the total environment.

[34]  James A. Swenberg,et al.  Toxicology and Epidemiology: Improving the Science with a Framework for Combining Toxicological and Epidemiological Evidence to Establish Causal Inference , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  G. Swaen A framework for using epidemiological data for risk assessment , 2006, Human & experimental toxicology.

[36]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[37]  Igor Linkov,et al.  Use of Multicriteria Decision Analysis to Support Weight of Evidence Evaluation , 2011, Risk analysis : an official publication of the Society for Risk Analysis.

[38]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[39]  Jennifer Seed,et al.  Overview: Using Mode of Action and Life Stage Information to Evaluate the Human Relevance of Animal Toxicity Data , 2005, Critical reviews in toxicology.

[40]  E. V. Sargent,et al.  IS HEXAVALENT CHROMIUM CARCINOGENIC VIA INGESTION? A WEIGHT-OF-EVIDENCE REVIEW , 2002, Journal of toxicology and environmental health. Part A.

[41]  Vern R. Walker RISK CHARACTERIZATION AND THE WEIGHT OF EVIDENCE : ADAPTING GATEKEEPING CONCEPTS FROM THE COURTS , 1996 .

[42]  D. Weed Weight of Evidence: A Review of Concept and Methods , 2005, Risk analysis : an official publication of the Society for Risk Analysis.

[43]  Ord,et al.  Supplemental Guidance for Assessing Susceptibility from Early-Life Exposure to Carcinogens , 2013 .

[44]  Siobhan M. Dolan,et al.  Assessment of cumulative evidence on genetic associations: interim guidelines. , 2008, International journal of epidemiology.

[45]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration , 2013 .

[46]  Gordon H Guyatt,et al.  GrADe : what is “ quality of evidence ” and why is it important to clinicians ? rATING quALITY of evIDeNCe AND STreNGTH of reCommeNDATIoNS , 2022 .

[47]  A. Boobis,et al.  The Key Events Dose-Response Framework: A Cross-Disciplinary Mode-of-Action Based Approach to Examining Dose-Response and Thresholds , 2009, Critical reviews in food science and nutrition.

[48]  Ord,et al.  Guidelines for Developmental Toxicity Risk Assessment , 2014 .

[49]  Rosa García Couto Globally Harmonized System of Classification and Labelling of Chemicals (GHS) , 2009 .

[50]  R. Prueitt,et al.  Hypothesis-based weight-of-evidence evaluation of the neurodevelopmental effects of chlorpyrifos , 2011, Critical reviews in toxicology.

[51]  C. Emond,et al.  A weight of evidence approach for the assessment of the ototoxic potential of industrial chemicals , 2012, Toxicology and industrial health.

[52]  Christopher Bevan,et al.  Best Practices for Evaluating Method Validity, Data Quality and Study Reliability of Toxicity Studies for Chemical Hazard and Risk Assessments , 2013 .

[53]  R. Preston,et al.  Application of Key Events Analysis to Chemical Carcinogens and Noncarcinogens , 2009, Critical reviews in food science and nutrition.

[54]  Guidance for Industry : Evidence-Based Review System for the Scientific Evaluation of Health Claims-Final , 2010 .

[55]  Koji Arizono,et al.  Why Public Health Agencies Cannot Depend on Good Laboratory Practices as a Criterion for Selecting Data: The Case of Bisphenol A , 2008, Environmental health perspectives.

[56]  Ord,et al.  Guidelines for Mutagenicity Risk Assessment , 2013 .

[57]  M Younes,et al.  IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. , 2001, Regulatory toxicology and pharmacology : RTP.

[58]  Office on Smoking The Health Consequences of Smoking: A Report of the Surgeon General , 2004 .